On the other hand, it is noteworthy that H. pylori eradication is unable to normalize any molecular abnormality for MSI and hMLH1 in patients with early GC who undergo ESD [8], which supports the contention that H. pylori eradication cannot necessarily prevent the development of metachronous GC [35]. The gene discussed is MLH1; the disease is gastric cancer.